EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment

Li Li, Lu Yu iD, Zigang Xu, Li Wei, Bin Zhang iD, Xiaofeng Han, Yujuan Sun, Lin Ma

Journal of Cosmetic Dermatology · 2023

DOI: 10.1111/jocd.15823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Li Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Hemangioma, Skin Neoplasms, Liver Neoplasms. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, Chinese Association of Rehabilitation Medicine Scientific Research, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Infantile hepatic hemangioma (IHH) is a common liver tumor in infants and shares the same characteristics as cutaneous infantile hemangioma (IH). Propranolol is effective for symptomatic IHH. The clinical features between cutaneous IH and IHH, and treatment efficacy of IHH (smaller than 4 cm) is unclear. To evaluate the correlation of clinical features between cutaneous IH and IHH, as well as efficacy of systemic propranolol in the treatment of cutaneous IH combined with IHH. Materials and Methods The clinical data of infants with complicated cutaneous IH combined with IHH treated with systemic propranolol (1.5 ~ 2 mg/(kg d)) from January 2011 to October 2020 were retrospectively analyzed.

Results

Forty‐five cases with IHH combined with complicated cutaneous IH were reviewed. Single cutaneous IH is more likely to be combined with focal IHH, cutaneous IH greater than 5, more likely to be combined with multiple IHH (Pearson = 0.546, p < 0.01). The mean age of focal and multiple IHH regression was 11.93 ± 14.42 months and 10.20 ± 9.15 months, respectively.

Conclusions

The number of cutaneous IH were correlated with the number of IHH. There was no difference in the age of complete remission for focal and multiple IHH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemangiomaSkin NeoplasmsLiver NeoplasmsInfantHumansChild, PreschoolPropranololRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

infantile hemangiomainfantile hepatic hemangiomapropranolol

Substanzen

Propranolol

Autor:innen und Institutionen

  • Department of Dermatology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing, China.

ORCID-Profile: Lu Yu, Bin Zhang

Förderung

  • Beijing Municipal Natural Science Foundation
  • Chinese Association of Rehabilitation Medicine Scientific Research
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Li, L., Yu, L., Xu, Z., Wei, L., Zhang, B., Han, X., Sun, Y., & Ma, L. (2023). Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15823

Vancouver

Li L, Yu L, Xu Z, Wei L, Zhang B, Han X, et al. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15823

BibTeX
@article{Li2023,
  author = {Li, Li and Yu, Lu and Xu, Zigang and Wei, Li and Zhang, Bin and Han, Xiaofeng and Sun, Yujuan and Ma, Lin},
  title = {Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment},
  journal = {Journal of Cosmetic Dermatology},
  year = {2023},
  doi = {10.1111/jocd.15823}
}
Kostenlos starten →